CDK4 inhibitor CAS 1256963-02-6 is a selective inhibitor of cyclin-dependent kinase 4 with IC50 value of 10 nM and also a member of the cyclin-dependent kinase family which play an important role in the G1-S phase. The CDK4 inhibitor, also called LEE011, CDK4/6 inhibitor and Ribociclib, is known for its concentrated formulation, greater efficiency and good results. We can offer kilogram grade LEE011 CAS NO 1256963-02-6 and supply fast delivery.
Thera. Category: CDK4/6 inhibitor
Cas No.: 1256963-02-6
Synonym: LEE011;CDK4/6 inhibitor;CDK4 inhibitor;CDK4-IN-1;Ribociclib;4-(5-Chloro-3-isopropyl-1H-pyrazol-4-yl)-N-(5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)pyrimidin-2-amine;Ribociclib(LEE011);Ribociclib(Lee011 & CDK 4/6 inhibitor)
Molecular Formula:C22H29ClN8
Molecular Weight:440.97226
Assay: ≥99.%
Packing: Export worthy packing
lMaterial Safety Data Sheet: Available on request
Usage: Ribociclib is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.